{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:38:52Z","timestamp":1761176332726,"version":"build-2065373602"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,22]]},"DOI":"10.7759\/cureus.95133","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:04:36Z","timestamp":1761127476000},"source":"Crossref","is-referenced-by-count":0,"title":["Famotidine-Induced Rash and Eosinophilia: A Case Report"],"prefix":"10.7759","author":[{"given":"Abeera","family":"Junaid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Graggaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15050614","article-title":"From rash decisions to critical conditions: a systematic review of dermatological presentations in emergency departments","volume":"15","author":"Algarni AS","year":"2025","unstructured":"Algarni AS, Alshiakh SM, Alghamdi SM, et al.. From rash decisions to critical conditions: a systematic review of dermatological presentations in emergency departments. Diagnostics (Basel). 2025, 15:4. 10.3390\/diagnostics15050614","journal-title":"Diagnostics (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2008.03155.x","article-title":"BSACI guidelines for the management of drug allergy","volume":"39","author":"Mirakian R","year":"2009","unstructured":"Mirakian R, Ewan PW, Durham SR, et al.. BSACI guidelines for the management of drug allergy. Clin Exp Allergy. 2009, 39:43-61. 10.1111\/j.1365-2222.2008.03155.x","journal-title":"Clin Exp Allergy"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2174\/138161206778194042","article-title":"Immediate hypersensitivity reactions to penicillins and other betalactams","volume":"12","author":"Ant\u00fanez C","year":"2006","unstructured":"Ant\u00fanez C, Mart\u00edn E, Cornejo-Garc\u00eda JA, et al.. Immediate hypersensitivity reactions to penicillins and other betalactams. Curr Pharm Des. 2006, 12:3327-33. 10.2174\/138161206778194042","journal-title":"Curr Pharm Des"},{"key":"ref4","article-title":"Penicillin allergy","author":"Patterson RA","year":"2025","unstructured":"Patterson RA, Stankewicz HA. Penicillin allergy. StatPearls. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/cc6883","article-title":"Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units","volume":"12","author":"Abidi K","year":"2008","unstructured":"Abidi K, Khoudri I, Belayachi J, Madani N, Zekraoui A, Zeggwagh AA, Abouqal R. Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care. 2008, 12:R59. 10.1186\/cc6883","journal-title":"Crit Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2017.06.005","article-title":"Changes in eosinophil count during bacterial infection: revisiting an old marker to assess the efficacy of antimicrobial therapy","volume":"61","author":"Davido B","year":"2017","unstructured":"Davido B, Makhloufi S, Matt M, et al.. Changes in eosinophil count during bacterial infection: revisiting an old marker to assess the efficacy of antimicrobial therapy. Int J Infect Dis. 2017, 61:62-6. 10.1016\/j.ijid.2017.06.005","journal-title":"Int J Infect Dis"},{"key":"ref7","article-title":"Cutaneous adverse drug reaction","author":"Al Aboud DM","year":"2025","unstructured":"Al Aboud DM, Nessel TA, Hafsi W. Cutaneous adverse drug reaction. StatPearls. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref8","unstructured":"DermNet.Drug eruptions [Internet]. Hamilton (NZ). DermNet NZ; 2016 January. Available from. https:\/\/dermnetnz.org\/topics\/drug-eruptions."},{"key":"ref9","unstructured":"Drug eruptions. (2021). Accessed. September 15, 2025: https:\/\/dermnetnz.org\/topics\/drug-eruptions."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2174\/1574886316666211005102711","article-title":"Famotidine's possible cutaneous rash in COVID-19 patients: an adverse effect case series","volume":"17","author":"Salehi M","year":"2022","unstructured":"Salehi M, Khalili H, Jahani Z, Rasoolinejad M, Ghiasvanad F. Famotidine's possible cutaneous rash in COVID-19 patients: an adverse effect case series. Curr Drug Saf. 2022, 17:269-73. 10.2174\/1574886316666211005102711","journal-title":"Curr Drug Saf"},{"key":"ref11","article-title":"A case of famotidine-induced anaphylaxis","volume":"20","author":"Kim YI","year":"2010","unstructured":"Kim YI, Park CK, Park DJ, Wi JO, Han ER, Koh YI. A case of famotidine-induced anaphylaxis. J Investig Allergol Clin Immunol. 2010, 20:166-9.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2011.3.2.128","article-title":"Two cases of h(2)-receptor antagonist hypersensitivity and cross-reactivity","volume":"3","author":"Song WJ","year":"2011","unstructured":"Song WJ, Kim MH, Lee SM, et al.. Two cases of h(2)-receptor antagonist hypersensitivity and cross-reactivity. Allergy Asthma Immunol Res. 2011, 3:128-31. 10.4168\/aair.2011.3.2.128","journal-title":"Allergy Asthma Immunol Res"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1177\/135965350400900217","article-title":"Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study","volume":"9","author":"Nordstrom BL","year":"2004","unstructured":"Nordstrom BL, Oh K, Sacks ST, L'Italien GJ. Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study. Antivir Ther. 2004, 9:187-95.","journal-title":"Antivir Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp10X483292","article-title":"Stevens-Johnson syndrome secondary to oseltamivir (Tamiflu)","volume":"60","author":"Smith EV","year":"2010","unstructured":"Smith EV, Pynn MC, Blackford S, Leopold DJ. Stevens-Johnson syndrome secondary to oseltamivir (Tamiflu). Br J Gen Pract. 2010, 60:133-4. 10.3399\/bjgp10X483292","journal-title":"Br J Gen Pract"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_53_18","article-title":"Oseltamivir-induced toxic epidermal necrolysis in a patient with Cushing's disease","volume":"86","author":"Gonz\u00e1lez-Ramos J","year":"2020","unstructured":"Gonz\u00e1lez-Ramos J, Lamas C, Bell\u00f3n T, Ruiz-Bravo E, RamIrez E, Lerma V, Lecumberri B. Oseltamivir-induced toxic epidermal necrolysis in a patient with Cushing's disease. Indian J Dermatol Venereol Leprol. 2020, 86:515-8. 10.4103\/ijdvl.IJDVL_53_18","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2022.01.058","article-title":"Oseltamivir induced oral-only erythema multiforme","volume":"55","author":"Siemieniak S","year":"2022","unstructured":"Siemieniak S, Yoo MJ. Oseltamivir induced oral-only erythema multiforme. Am J Emerg Med. 2022, 55:232.e1-2. 10.1016\/j.ajem.2022.01.058","journal-title":"Am J Emerg Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/420074-famotidine-induced-rash-and-eosinophilia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:04:38Z","timestamp":1761127478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/420074-famotidine-induced-rash-and-eosinophilia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.95133","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,22]]}}}